🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 1 día
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
20/11/2007 9,17 9,76 9,10 9,74 +5,98% 7,20% 1.145.600
19/11/2007 9,44 9,45 9,05 9,19 -3,26% 4,24% 767.200
16/11/2007 9,82 9,94 9,39 9,50 -3,06% 5,60% 562.700
15/11/2007 10,00 10,10 9,76 9,80 -2,49% 3,40% 300.000
14/11/2007 10,11 10,15 9,93 10,05 +0,50% 2,18% 479.300
13/11/2007 10,17 10,17 9,94 10,00 +0,20% 2,26% 410.800
12/11/2007 9,92 10,19 9,88 9,98 +0,60% 3,12% 923.100
09/11/2007 10,09 10,22 9,85 9,92 -2,65% 3,67% 923.400
08/11/2007 9,75 10,21 9,75 10,19 +5,60% 4,72% 675.900
07/11/2007 10,11 10,39 9,65 9,65 -7,21% 7,32% 822.900
06/11/2007 10,05 10,41 10,05 10,40 +3,79% 3,58% 622.600
05/11/2007 9,81 10,34 9,75 10,02 +1,21% 6,01% 1.241.700
02/11/2007 9,50 10,22 9,50 9,90 +7,03% 7,58% 1.283.000
01/11/2007 9,80 9,93 9,19 9,25 +0,00% 7,55% 951.500
31/10/2007 9,17 9,35 9,09 9,25 +1,43% 2,84% 415.600
30/10/2007 9,37 9,43 9,00 9,12 -2,67% 4,59% 780.100
29/10/2007 9,62 9,77 9,22 9,37 -2,60% 5,72% 969.400
26/10/2007 9,94 9,99 9,58 9,62 -1,84% 4,12% 587.000
25/10/2007 10,17 10,17 9,76 9,80 -3,07% 4,03% 309.200
24/10/2007 10,24 10,24 9,99 10,11 -1,65% 2,44% 245.000
23/10/2007 10,12 10,28 10,04 10,28 +2,39% 2,37% 286.600
22/10/2007 9,93 10,19 9,80 10,04 +0,20% 3,93% 502.600
19/10/2007 10,54 10,54 9,97 10,02 -5,02% 5,41% 1.255.800
18/10/2007 10,37 10,56 10,26 10,55 +1,44% 2,89% 619.800
17/10/2007 10,67 10,80 10,34 10,40 -1,42% 4,31% 580.000
16/10/2007 10,82 10,85 10,45 10,55 -2,59% 3,70% 368.300
15/10/2007 10,95 11,19 10,75 10,83 -0,73% 4,02% 456.200
12/10/2007 10,65 10,97 10,51 10,91 +2,92% 4,32% 415.000
11/10/2007 10,58 10,85 10,43 10,60 +0,95% 3,97% 692.000
10/10/2007 10,12 10,84 10,11 10,50 +3,45% 7,21% 2.491.400